PortfoliosLab logo
Laboratory Corporation of America Holdings (LH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US50540R4092

CUSIP

50540R409

IPO Date

Mar 29, 1990

Highlights

Market Cap

$19.12B

EPS (TTM)

$8.85

PE Ratio

25.83

PEG Ratio

0.84

Total Revenue (TTM)

$9.83B

Gross Profit (TTM)

$2.66B

EBITDA (TTM)

$1.30B

Year Range

$190.25 - $258.59

Target Price

$270.51

Short %

2.93%

Short Ratio

2.69

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Laboratory Corporation of America Holdings, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


800.00%1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%NovemberDecember2025FebruaryMarchApril
919.20%
1,521.29%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Returns By Period

Laboratory Corporation of America Holdings had a return of -0.16% year-to-date (YTD) and 16.57% in the last 12 months. Over the past 10 years, Laboratory Corporation of America Holdings had an annualized return of 8.40%, while the S&P 500 had an annualized return of 10.11%, indicating that Laboratory Corporation of America Holdings did not perform as well as the benchmark.


LH

YTD

-0.16%

1M

-2.16%

6M

0.45%

1Y

16.57%

5Y*

11.03%

10Y*

8.40%

^GSPC (Benchmark)

YTD

-6.06%

1M

-3.27%

6M

-4.87%

1Y

9.44%

5Y*

14.30%

10Y*

10.11%

*Annualized

Monthly Returns

The table below presents the monthly returns of LH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20258.93%0.78%-7.29%-1.90%-0.16%
2024-2.20%-2.59%1.22%-7.82%-2.85%4.41%5.86%7.04%-2.79%2.14%5.96%-4.91%2.22%
20237.07%-4.78%-4.15%-1.18%-5.94%13.55%3.19%-2.40%-3.39%-0.66%8.98%4.79%13.83%
2022-13.64%-0.04%-2.80%-8.87%2.98%-5.01%11.87%-13.84%-9.08%8.32%8.81%-2.17%-24.41%
202112.46%4.81%6.30%4.25%3.24%0.50%7.36%2.44%-7.23%1.98%-0.59%10.12%54.36%
20203.68%0.17%-28.06%30.11%6.61%-5.25%16.14%-8.90%7.12%6.11%0.04%1.86%20.32%
201910.28%6.38%3.20%4.54%1.68%6.33%-3.11%0.02%0.26%-1.92%4.56%-1.81%33.88%
20189.40%-1.03%-6.34%5.56%5.76%-0.59%-2.33%-1.41%0.47%-7.56%-9.29%-13.24%-20.78%
20174.54%6.00%0.85%-2.31%-0.82%10.89%3.09%-1.28%-3.76%1.81%2.97%0.78%24.25%
2016-9.13%-2.23%6.64%6.99%2.10%1.81%7.13%-1.88%0.40%-8.83%0.41%2.01%3.83%
20156.38%7.19%2.49%-5.18%-1.35%2.77%5.01%-7.45%-7.93%13.16%-0.98%1.73%14.59%
2014-1.69%4.13%4.99%0.50%3.93%-0.18%1.26%3.41%-5.11%7.41%-4.25%3.12%18.09%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LH is 67, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LH is 6767
Overall Rank
The Sharpe Ratio Rank of LH is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of LH is 6262
Sortino Ratio Rank
The Omega Ratio Rank of LH is 6060
Omega Ratio Rank
The Calmar Ratio Rank of LH is 7171
Calmar Ratio Rank
The Martin Ratio Rank of LH is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for LH, currently valued at 0.46, compared to the broader market-2.00-1.000.001.002.003.00
LH: 0.46
^GSPC: 0.46
The chart of Sortino ratio for LH, currently valued at 0.85, compared to the broader market-6.00-4.00-2.000.002.004.00
LH: 0.85
^GSPC: 0.77
The chart of Omega ratio for LH, currently valued at 1.10, compared to the broader market0.501.001.502.00
LH: 1.10
^GSPC: 1.11
The chart of Calmar ratio for LH, currently valued at 0.42, compared to the broader market0.001.002.003.004.005.00
LH: 0.42
^GSPC: 0.47
The chart of Martin ratio for LH, currently valued at 1.91, compared to the broader market-5.000.005.0010.0015.0020.00
LH: 1.91
^GSPC: 1.94

The current Laboratory Corporation of America Holdings Sharpe ratio is 0.46. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Laboratory Corporation of America Holdings with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.46
0.46
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Dividends

Dividend History

Laboratory Corporation of America Holdings provided a 1.26% dividend yield over the last twelve months, with an annual payout of $2.88 per share. The company has been increasing its dividends for 2 consecutive years.


0.90%1.00%1.10%1.20%1.30%$0.00$0.50$1.00$1.50$2.00$2.50$3.00202220232024
Dividends
Dividend Yield
PeriodTTM202420232022
Dividend$2.88$2.88$2.68$1.86

Dividend yield

1.26%1.26%1.18%0.92%

Monthly Dividends

The table displays the monthly dividend distributions for Laboratory Corporation of America Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.72$0.00$0.00$0.72
2024$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.88
2023$0.00$0.62$0.00$0.00$0.62$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.68
2022$0.62$0.00$0.00$0.62$0.00$0.00$0.62$0.00$1.86

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
LH: 1.3%
Laboratory Corporation of America Holdings has a dividend yield of 1.26%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
LH: 19.8%
Laboratory Corporation of America Holdings has a payout ratio of 19.77%, which is below the market average. This means Laboratory Corporation of America Holdings returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-12.18%
-10.07%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Laboratory Corporation of America Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Laboratory Corporation of America Holdings was 96.05%, occurring on Aug 31, 1998. Recovery took 2078 trading sessions.

The current Laboratory Corporation of America Holdings drawdown is 12.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.05%Dec 31, 19911686Aug 31, 19982078Dec 4, 20063764
-46.58%Feb 18, 202025Mar 23, 202082Jul 20, 2020107
-44.38%Jul 23, 1990117Jan 7, 199154Mar 25, 1991171
-36.21%Jun 18, 2018132Dec 24, 2018286Feb 13, 2020418
-34.61%Jan 3, 2022195Oct 11, 2022

Volatility

Volatility Chart

The current Laboratory Corporation of America Holdings volatility is 11.83%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
11.83%
14.23%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Laboratory Corporation of America Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Laboratory Corporation of America Holdings is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
LH: 25.8
The chart displays the Price-to-Earnings (P/E) ratio for LH, comparing it with other companies in the Diagnostics & Research industry. Currently, LH has a P/E ratio of 25.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
1.02.03.04.05.06.0
LH: 0.8
The chart shows the Price/Earnings to Growth (PEG) ratio for LH compared to other companies in the Diagnostics & Research industry. LH currently has a PEG ratio of 0.8. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
LH: 1.5
This chart shows the Price-to-Sales (P/S) ratio for LH relative to other companies in the Diagnostics & Research industry. Currently, LH has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
LH: 2.4
The chart illustrates the Price-to-Book (P/B) ratio for LH in comparison with other companies in the Diagnostics & Research industry. Currently, LH has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items